Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
1.4
-119.02%
Never
—
-23.02%
20%
—
5 Years
Score1.4
Net Growth-119.02%
Net TrendNever
Net Income Consistency—
Rev Growth-23.02%
Rev Trend20%
Revenue Consistency—
USANA Health Sciences Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 327M to $ 925M and net income declined from $ 38M to $ 10M. Revenue increased in 15 of those 20 years; net income in 10.
Across USANA Health Sciences Inc's full reported history, from 1996 to 2025, revenue grew from $ 56M to $ 925M and net income grew from $ 5M to $ 10M. Revenue increased in 77% of the years measured; net income in 57%.
USANA Health Sciences Inc currently holds a 20-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 13.54 | — |
1 Year2025-08-12 | $ 30.07 | -54.97% |
5 Years2021-08-12 | $ 94.55 | -85.68% |
10 Years2016-08-12 | $ 66.12 | -79.52% |
20 Years2006-08-11 | $ 21.95 | -38.30% |
30 Years1996-08-12 | $ 3.47 | 290.34% |
All Time1996-07-25 | $ 2.63 | 415.81% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-12 | All Time1996-07-25 |
|---|---|---|---|---|---|---|---|
| Price | $ 13.54 | $ 30.07 | $ 94.55 | $ 66.12 | $ 21.95 | $ 3.47 | $ 2.63 |
| Return | — | -54.97% | -85.68% | -79.52% | -38.30% | 290.34% | 415.81% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 913M | -$ 22M | |
| 2025 | $ 925M | $ 10M | $ 158M |
| 2024 | $ 854M | $ 42M | $ 181M |
| 2023 | $ 921M | $ 63M | $ 330M |
| 2022 | $ 998M | $ 69M | $ 288M |
| 2021 | $ 1.18B | $ 116M | $ 239M |
| 2020 | $ 1.13B | $ 124M | $ 312M |
| 2019 | $ 1.06B | $ 100M | $ 234M |
| 2018 | $ 1.18B | $ 126M | $ 277M |
| 2017 | $ 1.04B | $ 62M | $ 247M |
| 2016 | $ 1.00B | $ 100M | $ 175M |
| 2015 | $ 918M | $ 94M | $ 143M |
| 2014 | $ 790M | $ 76M | $ 111M |
| 2013 | $ 718M | $ 79M | $ 145M |
| 2012 | $ 648M | $ 66M | $ 70M |
| 2011 | $ 581M | $ 50M | $ 50M |
| 2010 | $ 517M | $ 45M | $ 24M |
| 2009 | $ 436M | $ 33M | $ 13M |
| 2008 | $ 429M | $ 29M | $ 13M |
| 2007 | $ 423M | $ 45M | $ 12M |
| 2006 | $ 374M | $ 41M | $ 27M |
| 2005 | $ 327M | $ 38M | $ 10M |
| 2004 | $ 272M | $ 30M | $ 15M |
| 2003 | $ 200M | $ 20M | $ 18M |
| 2002 | $ 133M | $ 8M | $ 6M |
| 2001 | $ 114M | $ 2M | $ 2M |
| 2000 | $ 123M | $ 2M | $ 2M |
| 1999 | $ 129M | $ 5M | $ 1M |
| 1998 | $ 121M | $ 9M | $ 2M |
| 1997 | $ 85M | $ 6M | $ 2M |
| IPO1996 | $ 56M | $ 5M | $ 1M |
Explore beyond USNA
You're looking at USANA Health Sciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
